Tech Company Inital Public Offerings

Carbylan Therapeutics IPO

Operating out of Palo Alto, Carbylan Therapeutics is now a public company.

Transaction Overview

Announced On
4/9/2015
Transaction Type
IPO
Amount
$65,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
3181 Porter Dr.
Palo Alto, CA 94304
USA
Email Address
Overview
Carbylan was founded in 2005 to develop and market medical devices and device/drug combination products
Profile
Carbylan Therapeutics LinkedIn Company Profile
Social Media
Carbylan Therapeutics Company Twitter Account
Company News
Carbylan Therapeutics News
Facebook
Carbylan Therapeutics on Facebook
YouTube
Carbylan Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Renzi
  David Renzi LinkedIn Profile  David Renzi Twitter Account  David Renzi News  David Renzi on Facebook
Chief Financial Officer
Michael White
  Michael White LinkedIn Profile  Michael White Twitter Account  Michael White News  Michael White on Facebook
VP - R & D
David Gravett
  David Gravett LinkedIn Profile  David Gravett Twitter Account  David Gravett News  David Gravett on Facebook
VP - Regulatory Affairs
Hayley Lewis
  Hayley Lewis LinkedIn Profile  Hayley Lewis Twitter Account  Hayley Lewis News  Hayley Lewis on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/9/2015: Domo venture capital transaction
Next: 4/9/2015: Palerra venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary